acute myeloid leukemia, leukemia stem cells, E-selectin, Bcl-2, antagonist
TP53 mutations, Clonal hematopoiesis (CH), Acute myeloid leukemia (AML), Mdm2 haploinsufficiency, Myeloid-biased hematopoiesis, Hematopoietic stem cells